Marcus-hillert Mosgau-Schultze
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
The Effects of Elinzanetant on Simulated Driving Performance in Healthy Women: A Randomized Phase I Study.
Journal: Clinical and translational science
Published: March 21, 2025
Mass Balance Recovery, Absorption, Metabolism, and Excretion of Elinzanetant in Healthy Human Volunteers and in vitro Biotransformation.
Journal: European journal of drug metabolism and pharmacokinetics
Published: November 25, 2024
Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II data.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 14, 2024
Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers.
Journal: European journal of drug metabolism and pharmacokinetics
Published: October 29, 2023
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling.
Journal: Clinical pharmacology and therapeutics
Published: August 17, 2023
Single- and Multiple-Dose Pharmacokinetics and Safety of Vilaprisan in Healthy Postmenopausal Japanese Women: A Randomized Clinical Trial.
Journal: European journal of drug metabolism and pharmacokinetics
Published: September 26, 2021
Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview.
Journal: Clinical pharmacokinetics
Published: August 27, 2021
Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan for the treatment of patients with uterine fibroids by exposure-response modelling and simulation.
Journal: British journal of clinical pharmacology
Published: February 18, 2021
Effect of Food Intake on the Pharmacokinetics of the Selective Progesterone Receptor Modulator Vilaprisan: A Randomized Clinical Study in Healthy Postmenopausal Women.
Journal: Clinical pharmacology in drug development
Published: July 21, 2020
Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women.
Journal: Clinical pharmacology in drug development
Published: May 19, 2020
The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive-A randomized controlled trial.
Journal: British journal of clinical pharmacology
Published: March 13, 2020
Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment.
Journal: Journal of clinical pharmacology
Published: January 21, 2020
Last Updated: 09/26/2026